BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32475629)

  • 1. Population-based matching comparison between radiofrequency ablation and percutaneous ethanol or acetic acid injection for hepatocellular carcinoma.
    Chang YJ; Chen LJ; Chang YJ; Chen PD
    Eur J Surg Oncol; 2020 Sep; 46(9):1703-1710. PubMed ID: 32475629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.
    Germani G; Pleguezuelo M; Gurusamy K; Meyer T; Isgrò G; Burroughs AK
    J Hepatol; 2010 Mar; 52(3):380-8. PubMed ID: 20149473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less.
    Lin SM; Lin CJ; Lin CC; Hsu CW; Chen YC
    Gut; 2005 Aug; 54(8):1151-6. PubMed ID: 16009687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
    Weis S; Franke A; Berg T; Mössner J; Fleig WE; Schoppmeyer K
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006745. PubMed ID: 25620061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma ≤ 4 cm treated with radiofrequency ablation with or without percutaneous ethanol injection.
    Shi F; Tan Z; An H; Wang X; Xu Y; Wang S
    Ann Hepatol; 2016; 15(1):61-70. PubMed ID: 26626642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival advantage of radiofrequency ablation for hepatocellular carcinoma: comparison with ethanol injection.
    Oeda S; Mizuta T; Isoda H; Kuwashiro T; Iwane S; Takahashi H; Kawaguchi Y; Eguchi Y; Ozaki I; Tanaka K; Fujimoto K
    Hepatogastroenterology; 2013 Sep; 60(126):1399-404. PubMed ID: 23635508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1-5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study.
    Chen S; Peng Z; Lin M; Chen Z; Hu W; Xie X; Liu L; Qian G; Peng B; Li B; Kuang M
    Eur Radiol; 2018 Sep; 28(9):3651-3660. PubMed ID: 29600474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Liu W; Zheng Y; He W; Zou R; Qiu J; Shen J; Yang Z; Zhang Y; Wang C; Wang Y; Zuo D; Li B; Yuan Y
    Aliment Pharmacol Ther; 2018 Sep; 48(6):671-681. PubMed ID: 30063081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study.
    Tsai WL; Cheng JS; Lai KH; Lin CP; Lo GH; Hsu PI; Yu HC; Lin CK; Chan HH; Chen WC; Chen TA; Li WL; Liang HL
    Aliment Pharmacol Ther; 2008 Aug; 28(3):304-11. PubMed ID: 19086330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery.
    Chen S; Peng Z; Xiao H; Lin M; Chen Z; Jiang C; Hu W; Xie X; Liu L; Peng B; Kuang M
    Int J Hyperthermia; 2018 Nov; 34(7):1029-1037. PubMed ID: 28974113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single hepatocellular carcinoma smaller than 2 cm: are ethanol injection and radiofrequency ablation equally effective?
    Pompili M; De Matthaeis N; Saviano A; De Sio I; Francica G; Brunello F; Cantamessa A; Giorgio A; Scognamiglio U; Fornari F; Giangregorio F; Piscaglia F; Gualandi S; Caturelli E; Roselli P; Riccardi L; Rapaccini GL
    Anticancer Res; 2015 Jan; 35(1):325-32. PubMed ID: 25550567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study.
    Huo TI; Huang YH; Wu JC; Lee PC; Chang FY; Lee SD
    Scand J Gastroenterol; 2003 Jul; 38(7):770-8. PubMed ID: 12889565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation combined with percutaneous ethanol injection in patients with hepatocellular carcinoma.
    Azab M; Zaki S; El-Shetey AG; Abdel-Moty MF; Alnoomani NM; Gomaa AA; Abdel-Fatah S; Mohiy S; Atia F
    Arab J Gastroenterol; 2011 Sep; 12(3):113-8. PubMed ID: 22055587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Local Tumor Progression in Perivascular Hepatocellular Carcinoma by Combination Therapy with Radiofrequency Ablation and Percutaneous Ethanol Injection: A Propensity Score Matching Analysis.
    Takata K; Tanaka T; Anan A; Fukunaga A; Nagata T; Fukuda H; Yamauchi R; Kunimoto H; Yokoyama K; Morihara D; Takeyama Y; Iwata K; Shakado S; Sakisaka S; Hirai F
    Oncology; 2022; 100(6):303-312. PubMed ID: 35114665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.
    Takayasu K; Arii S; Sakamoto M; Matsuyama Y; Kudo M; Kaneko S; Nakashima O; Kadoya M; Izumi N; Takayama T; Ku Y; Kumada T; Kubo S; Kokudo T; Hagiwara Y; Kokudo N;
    Liver Int; 2018 Mar; 38(3):484-493. PubMed ID: 29266722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous local ablation therapy in small hepatocellular carcinoma.
    Lin SM; Lin DY
    Chang Gung Med J; 2003 May; 26(5):308-14. PubMed ID: 12934846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of percutaneous ethanol injection versus radiofrequency ablation for single hepatocellular carcinoma no larger than 5 cm.
    Yang P; Li N
    J Int Med Res; 2022 Jul; 50(7):3000605221111281. PubMed ID: 35861264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carcinoma.
    Luo BM; Wen YL; Yang HY; Zhi H; Xiao XY; Ou B; Pan JS; Ma JH
    World J Gastroenterol; 2005 Oct; 11(40):6277-80. PubMed ID: 16419155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma.
    Bouza C; López-Cuadrado T; Alcázar R; Saz-Parkinson Z; Amate JM
    BMC Gastroenterol; 2009 May; 9():31. PubMed ID: 19432967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.